{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:28:05Z","timestamp":1790706485113,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Clinical Electrophysiology"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.jacep.2023.12.011","type":"journal-article","created":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T15:41:38Z","timestamp":1709134898000},"page":"718-730","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Impact of Atrial Fibrillation Burden on\u00a0Health Care Costs and Utilization"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2388-8896","authenticated-orcid":false,"given":"Graham","family":"Peigh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6367-9917","authenticated-orcid":false,"given":"Jiani","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah C.","family":"Rosemas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony I.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen","family":"Longacre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9529-8908","authenticated-orcid":false,"given":"Tanvi","family":"Nayak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabrielle","family":"Schwab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Soderlund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rod S.","family":"Passman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacep.2023.12.011_bib1","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1161\/CIRCOUTCOMES.110.958165","article-title":"Estimation of total incremental health care costs in patients with atrial fibrillation in the United States","volume":"4","author":"Kim","year":"2011","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacep.2023.12.011_bib2","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/j.amjcard.2009.07.022","article-title":"Increasing prevalence of atrial fibrillation and flutter in the United States","volume":"104","author":"Naccarelli","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacep.2023.12.011_bib3","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1161\/CIRCRESAHA.120.316340","article-title":"Epidemiology of atrial fibrillation in the 21st century: novel methods and new insights","volume":"127","author":"Kornej","year":"2020","journal-title":"Circ Res"},{"key":"10.1016\/j.jacep.2023.12.011_bib4","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1586\/14737167.2014.940904","article-title":"Cost-of-illness studies of atrial fibrillation: methodological considerations","volume":"14","author":"Becker","year":"2014","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"10.1016\/j.jacep.2023.12.011_bib5","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1186\/s12913-017-2652-y","article-title":"Cost of illness of atrial fibrillation: a nationwide study of societal impact","volume":"17","author":"Johnsen","year":"2017","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.jacep.2023.12.011_bib6","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/1747493018765491","article-title":"Impact of atrial fibrillation on inpatient cost for ischemic stroke in the USA","volume":"14","author":"Mukherjee","year":"2019","journal-title":"Int J Stroke"},{"key":"10.1016\/j.jacep.2023.12.011_bib7","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/j.1540-8167.2007.00819.x","article-title":"Healthcare resource utilization and costs associated with recurrent episodes of atrial fibrillation: the FRACTAL registry","volume":"18","author":"Reynolds","year":"2007","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacep.2023.12.011_bib8","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jval.2011.09.009","article-title":"A\u00a0review of the cost of atrial fibrillation","volume":"15","author":"Wodchis","year":"2012","journal-title":"Value Health"},{"key":"10.1016\/j.jacep.2023.12.011_bib9","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0002-8703(03)00524-6","article-title":"Cost of care distribution in atrial fibrillation patients: the COCAF study","volume":"147","author":"Le Heuzey","year":"2004","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacep.2023.12.011_bib10","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1185\/030079905X65475","article-title":"Economic burden and co-morbidities of atrial fibrillation in a privately insured population","volume":"21","author":"Wu","year":"2005","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jacep.2023.12.011_bib11","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.hroo.2022.07.010","article-title":"Healthcare utilization and costs associated with a diagnosis of incident atrial fibrillation","volume":"3","author":"Deshmukh","year":"2022","journal-title":"Heart Rhythm O2"},{"key":"10.1016\/j.jacep.2023.12.011_bib12","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1161\/CIRCEP.109.877852","article-title":"Performance of a new leadless implantable cardiac monitor in detecting and quantifying atrial fibrillation: results of the XPECT trial","volume":"3","author":"Hindricks","year":"2010","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacep.2023.12.011_bib13","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1046\/j.1540-8167.2004.03537.x","article-title":"Accuracy of mode switch algorithms for detection of atrial tachyarrhythmias","volume":"15","author":"Passman","year":"2004","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacep.2023.12.011_bib14","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1161\/CIRCEP.109.849638","article-title":"The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: the TRENDS study","volume":"2","author":"Glotzer","year":"2009","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacep.2023.12.011_bib15","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1111\/j.1540-8159.2004.00569.x","article-title":"Accuracy of atrial tachyarrhythmia detection in implantable devices with arrhythmia therapies","volume":"27","author":"Purerfellner","year":"2004","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.jacep.2023.12.011_bib16","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1016\/j.jacc.2014.04.019","article-title":"Clinical classifications of atrial fibrillation poorly reflect its temporal persistence: insights from 1,195 patients continuously monitored with implantable devices","volume":"63","author":"Charitos","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2023.12.011_bib17","doi-asserted-by":"crossref","first-page":"e623","DOI":"10.1161\/CIR.0000000000000568","article-title":"Atrial fibrillation burden: moving beyond atrial fibrillation as a binary entity: a scientific statement from the American Heart Association","volume":"137","author":"Chen","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2023.12.011_bib18","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1161\/CIRCULATIONAHA.119.041303","article-title":"Stroke risk as a function of atrial fibrillation duration and CHA(2)DS(2)-VASc score","volume":"140","author":"Kaplan","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2023.12.011_bib19","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1161\/01.CIR.101.8.878","article-title":"Detection of atrial fibrillation and flutter by a dual-chamber implantable cardioverter-defibrillator. For the Worldwide Jewel AF Investigators","volume":"101","author":"Swerdlow","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2023.12.011_bib20","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.ahj.2006.02.016","article-title":"ASymptomatic atrial fibrillation and Stroke Evaluation in pacemaker patients and the atrial fibrillation Reduction atrial pacing Trial (ASSERT)","volume":"152","author":"Hohnloser","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacep.2023.12.011_bib21","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.hrthm.2012.03.017","article-title":"Positive predictive value of device-detected atrial high-rate episodes at different rates and durations: an analysis from ASSERT","volume":"9","author":"Kaufman","year":"2012","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2023.12.011_bib22","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ahj.2017.04.008","article-title":"Rationale and design of the Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation (ARTESiA) trial","volume":"189","author":"Lopes","year":"2017","journal-title":"Am Heart J"},{"issue":"2","key":"10.1016\/j.jacep.2023.12.011_bib23","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa2310234","article-title":"Apixaban for stroke prevention in subclinical atrial\u00a0fibrillation","volume":"390","author":"Healey","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacep.2023.12.011_bib24","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s12874-021-01440-5","article-title":"Major adverse cardiovascular event definitions used in observational analysis of administrative databases: a systematic review","volume":"21","author":"Bosco","year":"2021","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.jacep.2023.12.011_bib25","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s12325-020-01536-2","article-title":"Real-world economic burden among patients with and without heart failure worsening after cardiac resynchronization therapy","volume":"38","author":"Chung","year":"2021","journal-title":"Adv Ther"},{"key":"10.1016\/j.jacep.2023.12.011_bib26","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1001\/archinte.158.3.229","article-title":"Impact of atrial fibrillation on mortality, stroke, and medical costs","volume":"158","author":"Wolf","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacep.2023.12.011_bib27","first-page":"281","article-title":"Direct treatment cost of atrial fibrillation in the elderly American population: a Medicare perspective","volume":"11","author":"Lee","year":"2008","journal-title":"J\u00a0Med Econ"},{"key":"10.1016\/j.jacep.2023.12.011_bib28","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2014.03.022","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society","volume":"64","author":"January","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2023.12.011_bib29","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ahj.2021.11.006","article-title":"Association between economic and arrhythmic burden of paroxysmal atrial fibrillation in patients with cardiac implanted electronic devices","volume":"244","author":"Chew","year":"2022","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacep.2023.12.011_bib30","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1111\/jce.14311","article-title":"Ablation of persistent atrial fibrillation: challenges and solutions","volume":"31","author":"Terricabras","year":"2020","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacep.2023.12.011_bib31","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1136\/heartjnl-2020-317422","article-title":"Contemporary management of persistent atrial fibrillation","volume":"108","author":"Gupta","year":"2022","journal-title":"Heart"},{"key":"10.1016\/j.jacep.2023.12.011_bib32","article-title":"Assessment of CHA2DS2-VASc score for predicting cardiovascular and cerebrovascular outcomes in acute myocardial infarction patients","volume":"97","author":"Li","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jacep.2023.12.011_bib33","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/eurheartj\/ehac692","article-title":"Healthcare utilization and quality of life for atrial fibrillation burden: the CIRCA-DOSE study","volume":"44","author":"Andrade","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacep.2023.12.011_bib34","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1161\/CIRCRESAHA.117.309732","article-title":"Atrial fibrillation: epidemiology, pathophysiology, and clinical outcomes","volume":"120","author":"Staerk","year":"2017","journal-title":"Circ Res"},{"key":"10.1016\/j.jacep.2023.12.011_bib35","doi-asserted-by":"crossref","first-page":"231","DOI":"10.5455\/msm.2017.29.231-236","article-title":"The Impact of risk factors and comorbidities on the incidence of atrial fibrillation","volume":"29","author":"Naser","year":"2017","journal-title":"Mater Sociomed"},{"key":"10.1016\/j.jacep.2023.12.011_bib36","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/1753944712464101","article-title":"Burden of comorbidities among patients with atrial fibrillation","volume":"7","author":"LaMori","year":"2013","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"10.1016\/j.jacep.2023.12.011_bib37","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000016560","article-title":"Predictive value of CHA2DS2-VASc scores regarding the risk of stroke and all-cause mortality in patients with atrial fibrillation (CONSORT compliant)","volume":"98","author":"Gazova","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jacep.2023.12.011_bib38","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1111\/crj.12624","article-title":"CHA2DS2-VASc scores predict major adverse cardiovascular events in patients with chronic obstructive pulmonary disease","volume":"12","author":"Ooi","year":"2018","journal-title":"Clin Respir J"},{"key":"10.1016\/j.jacep.2023.12.011_bib39","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1159\/000508836","article-title":"Assessment of the CHA2DS2-VASc score in predicting mortality and adverse cardiovascular outcomes of patients on hemodialysis","volume":"51","author":"Schamroth Pravda","year":"2020","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.jacep.2023.12.011_bib40","first-page":"10","article-title":"CHA2DS2-VASc score for major adverse cardiovascular events stratification in patients with pneumonia with and without atrial fibrillation","author":"Wang","year":"2021","journal-title":"J\u00a0Clin Med"}],"container-title":["JACC: Clinical Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405500X24000057?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405500X24000057?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,13]],"date-time":"2025-04-13T08:04:49Z","timestamp":1744531489000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405500X24000057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S2405500X24000057"],"URL":"https:\/\/doi.org\/10.1016\/j.jacep.2023.12.011","relation":{},"ISSN":["2405-500X"],"issn-type":[{"value":"2405-500X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of Atrial Fibrillation Burden on\u00a0Health Care Costs and Utilization","name":"articletitle","label":"Article Title"},{"value":"JACC: Clinical Electrophysiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacep.2023.12.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}